Literature DB >> 1476704

Purpurogallin is a more powerful protector of kidney cells than Trolox and allopurinol.

L H Zeng1, T W Wu.   

Abstract

Phase contrast and electron microscopic experiments demonstrated that oxyradicals generated with xanthine oxidase and hypoxanthine markedly damage rat kidney mesangial and porcine tubular epithelial cells. Purpurogallin, a phenol found in oak nutgalls, prolongs survival of the xanthine oxidase exposed renal cells three- to nine-fold longer than those without purpurogallin present. At levels equimolar to purpurogallin, either Trolox or allopurinol is less effective in delaying cell necrosis. Purpurogallin scavenges not only xanthine oxidase generated oxyradicals, but also non-enzymatically produced peroxyl radicals, more actively than equimolar levels of Trolox or allopurinol. Purpurogallin inhibits xanthine oxidase with severalfold higher potency than allopurinol and its more active metabolite oxypurinol. Therefore, purpurogallin is a stronger antioxidant than Trolox and a more potent inhibitor of xanthine oxidase than allopurinol as well as oxypurinol.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1476704     DOI: 10.1139/o92-104

Source DB:  PubMed          Journal:  Biochem Cell Biol        ISSN: 0829-8211            Impact factor:   3.626


  3 in total

1.  Purpurogallin Reverses Neuronal Apoptosis and Enhances "M2" Polarization of Microglia Under Ischemia via Mediating the miR-124-3p/TRAF6/NF-κB Axis.

Authors:  Zongxin Cheng; Xinming Li; Xiaohua Ye; Rong Yu; Youqing Deng
Journal:  Neurochem Res       Date:  2022-09-21       Impact factor: 4.414

2.  Integrated Bioinformatics and Clinical Correlation Analysis of Key Genes, Pathways, and Potential Therapeutic Agents Related to Diabetic Nephropathy.

Authors:  Shengnan Chen; Lei Chen; Hongli Jiang
Journal:  Dis Markers       Date:  2022-05-21       Impact factor: 3.464

3.  Antiplatelet and antithrombotic activities of purpurogallin in vitro and in vivo.

Authors:  Sae-Kwang Ku; Jong-Sup Bae
Journal:  BMB Rep       Date:  2014-07       Impact factor: 4.778

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.